Atlas Trials

Substudy 'B' of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)

Clinical trial NCT02404532 · COMPLETED

Trial details

NCT number
NCT02404532
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Device Latency
Start date
2015-02-01
Primary completion
2015-02-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.